Greenhaven’s Devilish Gambit in Avantor’s Lab

The transaction, 18,311,570 shares of Avantor, was no mere wager but a calculated stroke of the pen. Greenhaven’s coffers now brim with these shares, their value unyielding at $228.53 million, as if the market had been instructed to pause its chaos for a moment.





